You can see the previous lines of therapy these patients had used in the announement. A number of these therapies would be considered chemotherapy includng cytarabine/dauno, idarubicine and fludarabine. Venetoclax, gilteritinib and the CAR-T would probably not be considered "chemotherapy" although the term is a bit vague.
- Forums
- ASX - By Stock
- Ann: Impressive Bisantrene Phase 2 AML Clinical Results
You can see the previous lines of therapy these patients had...
-
- There are more pages in this discussion • 164 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.49 |
Change
-0.035(2.30%) |
Mkt cap ! $257.4M |
Open | High | Low | Value | Volume |
$1.55 | $1.55 | $1.45 | $225.9K | 151.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 600 | $1.49 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.49 | 24 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 650 | 1.510 |
1 | 600 | 1.485 |
1 | 650 | 1.455 |
2 | 35000 | 1.450 |
1 | 2000 | 1.445 |
Price($) | Vol. | No. |
---|---|---|
1.480 | 649 | 1 |
1.490 | 25 | 1 |
1.505 | 649 | 1 |
1.510 | 10381 | 3 |
1.540 | 1500 | 1 |
Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online